Back to SYRE
NORTHERN TRUST CORP SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
21
Latest value
$768K
Q3 2026
Peak value
$57.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $333K |
| Q4 2025 | $667K |
| Q4 2025 | $294K |
| Q4 2025 | $16.9M |
| Q4 2025 | $191K |
| Q4 2025 | $4K |
| Q1 2026 | $484K |
| Q1 2026 | $980K |
| Q1 2026 | $453K |
| Q1 2026 | $26.9M |
| Q1 2026 | $424K |
| Q2 2026 | $1M |
| Q2 2026 | $2M |
| Q2 2026 | $815K |
| Q2 2026 | $55.3M |
| Q2 2026 | $742K |
| Q3 2026 | $1M |
| Q3 2026 | $2.2M |
| Q3 2026 | $836K |
| Q3 2026 | $57.3M |
| Q3 2026 | $768K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $768K | 8.6K | — | — |
| Q3 2026 | $57.3M | 643.1K | — | — |
| Q3 2026 | $836K | 9.4K | — | — |
| Q3 2026 | $2.2M | 24.9K | — | — |
| Q3 2026 | $1M | 11.3K | — | — |
| Q2 2026 | $742K | 8.4K | — | — |
| Q2 2026 | $55.3M | 623.1K | — | — |
| Q2 2026 | $815K | 9.2K | — | — |
| Q2 2026 | $2M | 22.3K | — | — |
| Q2 2026 | $1M | 11.6K | — | — |
| Q1 2026 | $424K | 8.4K | — | — |
| Q1 2026 | $26.9M | 532.5K | — | — |
| Q1 2026 | $453K | 9.0K | — | — |
| Q1 2026 | $980K | 19.4K | — | — |
| Q1 2026 | $484K | 9.6K | — | — |
| Q4 2025 | $4K | 114 | — | — |
| Q4 2025 | $191K | 5.8K | — | — |
| Q4 2025 | $16.9M | 515.6K | — | — |
| Q4 2025 | $294K | 9.0K | — | — |
| Q4 2025 | $667K | 20.4K | — | — |
| Q4 2025 | $333K | 10.2K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M